Quantitative prediction of catalepsy induced by amoxapine, cinnarizine and cyclophosphamide in mice

Biopharmaceutics and Drug Disposition

Volumn 21, Issue 4, 2000, Pages 129-138

  Nasu, Risa ^a   Matsuo, Hirotami ^a   Takanaga, Hitomi ^a   Ohtani, Hisakazu ^a   Sawada, Yasufumi ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Amoxapine; Catalepsy; Cinnarizine; Cyclophosphamide; Parkinsonism; Receptor occupancy

Indexed keywords

AMOXAPINE; ANTIARRHYTHMIC AGENT; CALCIUM CHANNEL BLOCKING AGENT; CINNARIZINE; CYCLOPHOSPHAMIDE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; MUSCARINIC RECEPTOR; NEUROLEPTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CATALEPSY; CONTROLLED STUDY; CORPUS STRIATUM; DRUG RECEPTOR BINDING; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PARKINSONISM; PHARMACODYNAMICS; PREDICTION; RECEPTOR OCCUPANCY; SYNAPTIC MEMBRANE;

AMOXAPINE; ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; BIPERIDEN; CALCIUM CHANNEL BLOCKERS; CATALEPSY; CINNARIZINE; CORPUS STRIATUM; CYCLOPHOSPHAMIDE; DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; KINETICS; MALE; MICE; MUSCARINIC ANTAGONISTS; PREDICTIVE VALUE OF TESTS; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; RECEPTORS, MUSCARINIC;

EID: 0034511936     PISSN: 01422782     EISSN: None     Source Type: Journal    
DOI: 10.1002/1099-081X(200005)21:4<129::AID-BDD224>3.0.CO;2-F     Document Type: Article

References (31)

1. Drug-induced parkinsonism
2. Parkinsonism, tardive dyskinesia, akathisia, and depression induced by flunarizine
3. Parkinsonism, tardive dyskinesia, akathisia, and depression induced by flunarizine
4. Useless drugs are not placebos: Lessons from flunarizine and cinnarizine
5. Parkinsonism, depression and akathisia induced by flunarizine, a calcium entry blocker-report of 31 cases
6. A long-term follow-up study of cinnarizine- and flunarizine-induced parkinsonism
7. 2 dopamine receptors in neuroleptic catalepsy
8. 2, and muscarinic acetylcholine receptor occupancies
9. Prediction of catalepsies induced by amiodarone, aprindine and procaine: Similarity in conformation of diethylaminoethyl side chain
10. Catalepsy induced by manidipine, a calcium channel blocker, in mice
11. A pharmacokinetic analysis program (MULTI) for microcomputer
12. Catalepsy induced by calcium channel blockers in mice
13. Relationship between structure and drug-induced parkinsonis
14. Fundamental pharmacokinetic properties of biperiden: Tissue distribution and elimination in rabbits
15. Interaction of psychotropic drugs with brain muscarinic cholinoceptors: Similarities of biperiden with pirenzepine in receptor binding properties
16. Possible pharmacokinetic and pharmacodynamic factors affecting parkinsonism inducement by cinnarizine and flunarizine
17. 4 Dopamine receptor binding affinity does not distinguish between typical and atypical antipsychotic drugs
18. i values
19. Parkinsonian syndrome in a dialysis-supported patient receiving high-dose chemotherapy for multiple myeloma
20. A progressive parkinsonian syndrome developing after chemotherapy and radiotherapy for non-Hodgkin's lymphoma
21. 3H]raclopride for dopamine D-2 receptor binding to rat striatum
22. 2 receptor of normal human brain in vitro
23. Effect of drugs influencing central serotonergic mechanisms on haloperidol-induced catalepsy
24. The effect of serotonergic agents on haloperidol-induced catalepsy
25. Serotonergic involvement in haloperidol-induced catalepsy
26. 2 receptor synergism
27. 4 and serotonin(2A) receptors in antipsychotic and anticataleptic
28. S 16924 ((R)-2-[2-(2,3-dihydro-benzo[1,4] dioxin-5-yloxy)ethyl]-pyrrolidin- 3-yl}-1-(4-fluorophenyl)ethanone), a novel, potential antipsychotic with marked serotonin (5-HT)1A agonist properties: Functional profile in comparison to clozapine and haloperidol
29. General pharmacology of amoxapine
30. General pharmacology of antiarrhythmic drug, aprindine
31. Propiverine-induced Parkinsonism: A case report and a pharmacokinetic/ pharmacodynamic study in mice